SFG Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,385
Closed -$283K 124
2025
Q4
$283K Sell
11,385
-3,010
-21% -$75.9K 0.11% 111
2025
Q3
$367K Buy
14,395
+257
+2% +$6.34K 0.16% 97
2025
Q2
$343K Buy
14,138
+800
+6% +$18.7K 0.21% 63
2025
Q1
$338K Buy
13,338
+4,735
+55% +$124K 0.17% 93
2024
Q4
$228K Buy
+8,603
New +$233K 0.12% 90
2022
Q4
Sell
-4,584
Closed -$201K 84
2022
Q3
$201K Buy
+4,584
New +$223K 0.27% 73
2022
Q1
Sell
-3,576
Closed -$211K 98
2021
Q4
$211K Buy
+3,576
New +$177K 0.19% 91

Other funds holding PFE

SFG Wealth Management's PFE Position: Q1 2026 in Review

SFG Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 11,385 shares — an estimated $283K sold.

SFG Wealth Management first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $367K in Q3 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SFG Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • SFG Wealth Management sold 11,385 Pfizer shares in Q1 2026, an estimated $283K.
  • SFG Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
  • SFG Wealth Management's Pfizer position peaked at $367K in Q3 2025.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SFG Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.